| User's Publication |
|
22647
Wang C, Yang M, Zhong Y, Cao K, Wang X, Zhang C, Wang Y, He M, Lu J, Zhang G, Huang Y, Liu H.
Immunosuppressive JAG2+ tumor-associated neutrophils hamper PD-1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells.
Cancer Commun (Lond)
2025
PubMed ID: 40120139
DOI: 10.1002/cac2.70021
|
|
22898
Krishnaraj J, Ueno S, Nakamura M, Tabata Y, Yamamoto T, Asano Y, Tanaka T, Kuzuyama T, Saya H, Ohki R.
IER5 Promotes Ovarian Cancer Cell Proliferation and Peritoneal Dissemination
Cancers (Basel)
2025
17(4):610
PubMed ID: 40002205
DOI: 10.3390/cancers17040610
|
|
21694
Hirasawa H, Aoba K, Miwa N.
Acid-Sensitive Outwardly Rectifying Cl- Current in OV2944 Mouse Ovarian Cancer Cells.
Cell Physiol Biochem
2024
58(2):172-181
PubMed ID: 38643508
DOI: 10.33594/000000692
|
|
21132
Barberio AE, Smith SG, Pires IS, Iyer S, Reinhardt F, Melo MB, Suh H, Weinberg RA, Irvine DJ, Hammond PT.
Layer-by-layer interleukin-12 nanoparticles drive a safe and effective response in ovarian tumors.
Bioeng Transl Med
2023
8(2):e10453
PubMed ID: 36925719
DOI: 10.1002/btm2.10453
|
|
21220
Cao K, Zhang G, Yang M, Wang Y, He M, Zhang C, Huang Y, Lu J, Liu H.
Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer.
Cancer Res
2023
PubMed ID: 37172314
DOI: 10.1158/0008-5472.CAN-22-3260
|
|
20496
Ishikura N, Sugimoto M, Yorozu K, Kurasawa M, Kondoh O.
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
Oncol Rep
2022
47(2)
PubMed ID: 34958105
DOI: 10.3892/or.2021.8247
|
|
16437
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M.
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
Cancer Immunol Res
2022
10(1):56-69.
PubMed ID: 34799346
DOI: 10.1158/2326-6066.CIR-21-0407
|
|
20694
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M.
CXCL13-producing CD4+ T cells accumulate in early phase of tertiary lymphoid structures in ovarian cancer.
JCI Insight
2022
PubMed ID: 35552285
DOI: 10.1172/jci.insight.157215
|
|
14343
Goto S, Sakoda Y, Adachi K, Sekido Y, Yano S, Eto M, Tamada K.
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models
Cancer Immunol Immunother
2021
PubMed ID: 33559069
DOI: 10.1007/s00262-021-02853-3
|
|
20242
Mori T, Hazekawa M, Yoshida M, Nishinakagawa T, Uchida T, Ishibashi D.
Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells.
Int J Pharm
2021
120891
PubMed ID: 34324984
DOI: 10.1016/j.ijpharm.2021.120891
|
|
9914
Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Mana Taki, Masayo Ukita, Yuko Hosoe, Masafumi Koshiyama, Ikuo Konishi, Masaki Mandai
Anti-VEGF Therapy Resistance in Ovarian Cancer Is Caused by GM-CSF-induced Myeloid-Derived Suppressor Cell Recruitment
Br J Cancer
2020
122(6):778-788
PubMed ID: 31932754
DOI: 10.1038/s41416-019-0725-x
|
|
13079
Komura N, Mabuchi S, Shimura K, Yokoi E, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T.
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Cancer Immunol Immunother
2020
PubMed ID: 32561967
DOI: 10.1007/s00262-020-02628-2
|
|
13158
Yang M, Zhang G, Wang Y, He M, Xu Q, Lu J, Liu H, Xu C.
Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer.
Br J Cancer
2020
PubMed ID: 32778818
DOI: 10.1038/s41416-020-1026-0
|
|
13282
Han N, Anwar D, Hama N, Kobayashi T, Suzuki H, Takahashi H, Wada H, Otsuka R, Baghdadi M, Seino KI.
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells.
Inflamm Regen
2020
PubMed ID: 33072227
DOI: 10.1186/s41232-020-00129-4
|
|
16828
Barberio AE, Smith SG, Correa S, Nguyen C, Nhan B, Melo M, Tokatlian T, Suh H, Irvine DJ, Hammond PT.
Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery
ACS Nano
2020
14(9):11238-11253
PubMed ID: 32692155
DOI: 10.1021/acsnano.0c03109
|
|
11270
Mulati K, Hamanishi J, Matsumura N, Chamoto K, Mise N, Abiko K, Baba T, Yamaguchi K, Horikawa N, Murakami R, Taki M, Budiman K, Zeng X, Hosoe Y, Azuma M, Konishi I, Mandai M.
VISTA expressed in tumour cells regulates T cell function.
Br. J. Cancer
2019
PubMed ID: 30382166
DOI: 10.1038/s41416-018-0313-5
|
|
11603
Aoki N, Matsui Y.
Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells.
Mol. Cell. Biol.
2019
PubMed ID: 31208979
DOI: 10.1128/MCB.00154-19
|
|
6962
Hazekawa M, Nishinakagawa T, Kawakubo-Yasukochi T, Nakashima M.
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model.
J Pharmacol Sci
2019
139(3):231-239
PubMed ID: 30803892
DOI: 10.1016/j.jphs.2019.01.009
|
|
10833
Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N.
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
Nat Commun
2018
9:1685
PubMed ID: 29703902
DOI: 10.1038/s41467-018-03966-7
|
|
14925
Nakagawa S, Serada S, Kakubari R, Hiramatsu K, Sugase T, Matsuzaki S, Matsuzaki S, Ueda Y, Yoshino K, Ohkawara T, Fujimoto M, Kishimoto T, Kimura T, Naka T.
Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell-Mediated Antitumor Immunity By Suppressing PD-L1
Mol Cancer Ther
2018
17(9):1941-1950.
PubMed ID: 29891489
DOI: 10.1158/1535-7163.MCT-17-0822
|
|
14927
Taha AAA, Koshiyama M, Matsumura N, Abiko K, Yamaguchi K, Hamanishi J, Baba T, Kharma B, Mohamed IH, Ameen MM, Ismail SA, Konishi I, Mandai M.
The effect of the type of dietary protein on the development of ovarian cancer
Oncotarget
2018
9(35):23987-23999
PubMed ID: 29844867
DOI: 10.18632/oncotarget.25253
|
|
14348
Horikawa N, Abiko K, Matsumura N, Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y, Koshiyama M, Konishi I.
Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
Clin Cancer Res
2017
23(2):587-599
PubMed ID: 27401249
DOI: 10.1158/1078-0432.CCR-16-0387
|
|
7149
Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M.
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
Cancer Res.
2015
75:5034-45
PubMed ID: 26573793
DOI: 10.1158/0008-5472.CAN-14-3098
|
|
7194
Kobayashi A, Tanizaki Y, Kimura A, Ishida Y, Nosaka M, Toujima S, Kuninaka Y, Minami S, Ino K, Kondo T.
AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
Eur. J. Pharmacol.
2015
766:63-75
PubMed ID: 26410360
DOI: 10.1016/j.ejphar.2015.09.039
|
|
15068
Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M.
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
Br J Cancer
2015
112(9):1501-9
PubMed ID: 25867264
DOI: 10.1038/bjc.2015.101
|
|
9104
Fumi Goshima, Shinichi Esaki, Chenhong Luo, Maki Kamakura, Hiroshi Kimura, Yukihiro Nishiyama
Oncolytic Viral Therapy With a Combination of HF10, a Herpes Simplex Virus Type 1 Variant and Granulocyte-Macrophage Colony-Stimulating Factor for Murine Ovarian Cancer
Int J Cancer
2014
134 (12), 2865-77
PubMed ID: 24265099
DOI: 10.1002/ijc.28631
|
|
14926
Tanizaki Y, Kobayashi A, Toujima S, Shiro M, Mizoguchi M, Mabuchi Y, Yagi S, Minami S, Takikawa O, Ino K.
Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment
Cancer Sci
2014
105(8):966-73
PubMed ID: 24826982
DOI: 10.1111/cas.12445
|
|
17139
Manthana Mitchai, Niramon Leeratanapetch, Viraphong Lulitanond, Pattaravadee Srikoon, Shinichiro Hattori, Kulthida Vaeteewoottacharn, Sopit Wongkham, Seiji Okada
Phenotypic Characteristics and Function of NK Cell Subsets in cART-Treated HIV-1-Infected Individuals
World Journal of AIDS
2014
04:293-300
DOI: 10.4236/wja.2014.43034
|
|
18667
Toyoshima M, Tanaka Y, Matumoto M, Yamazaki M, Nagase S, Sugamura K, Yaegashi N.
Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging
Luminescence
2009
24(5):324-31
PubMed ID: 19711487
DOI: 10.1002/bio.1112
|
Back
Top
CELL BANK Website
